zen, last Friday when I filled my shopping cart with 'vaccine' biotechs, like 3 instantly initiated secondaries hence my additional skepticism about biotechs doing secondaries (on almost any spike in pps).
Now we have this new Fed-funding with $3B allotted for 'vaccine' advancement...$3B is a whole lot of cash...several of these obscure 'vaccine' stocks might very well get all the funding they need from the federal government? IPATF, APDN and several others are first-in-line imo.
See NNVC - sold all in afterhours on what I thought was a total hype pr...the sector is absolutely hothothot
Full transcript of the Trump meeting with big pharma companies. There were no 'little pharmas' in attendance as have been (and still being) pumped on these boards.
Entered or added this morning GILD, MRNA, NVAX, PFE, and GSK...